(Q39175955)

9 September 2017

title

Knockdown of AXL receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis (English)

1 reference

9 September 2017

Y Zhang

1

1 reference

9 September 2017

Y-J Tang

2

1 reference

9 September 2017

Y Man

3

1 reference

9 September 2017

F Pan

4

1 reference

9 September 2017

Z-H Li

5

1 reference

9 September 2017

L-S Jia

6

1 reference

9 September 2017

publication date

1 January 2013

1 reference

International Journal of Immunopathology and Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

26

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

179-188

1 reference

Historical, current and future aspects of osteosarcoma treatment

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Axl-dependent signalling: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Coexpression of Gas6/Axl in human ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Growth arrest-specific gene 6 expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

AXL is an essential factor and therapeutic target for metastatic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Evaluation of claspin as a proliferation marker in human cancer and normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201302600117

10.1177/039463201302600117

21 January 2018

Identifiers

DOI

1 reference

release_klsiviyo3jhzli5yyygsegknli

9 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/klsiviyo3jhzli5yyygsegknli

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference